您的购物车当前为空
N-desmethyl Rosiglitazone is a major metabolite of rosiglitazone , a potent and selective PPARγ ligand present in formulations that have been used to treat type 2 diabetes. Rosiglitazone is metabolized by the cytochrome P450 (CYP) isoform CYP2C8 to form N-desmethyl rosiglitazone.
N-desmethyl Rosiglitazone is a major metabolite of rosiglitazone , a potent and selective PPARγ ligand present in formulations that have been used to treat type 2 diabetes. Rosiglitazone is metabolized by the cytochrome P450 (CYP) isoform CYP2C8 to form N-desmethyl rosiglitazone.

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 5 mg | ¥ 6,910 | 35日内发货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
| 产品描述 | N-desmethyl Rosiglitazone is a major metabolite of rosiglitazone , a potent and selective PPARγ ligand present in formulations that have been used to treat type 2 diabetes. Rosiglitazone is metabolized by the cytochrome P450 (CYP) isoform CYP2C8 to form N-desmethyl rosiglitazone. |
| 分子量 | 343.4 |
| 分子式 | C17H17N3O3S |
| CAS No. | 257892-31-2 |
| Smiles | O=C1NC(=O)C(Cc2ccc(OCCNc3ccccn3)cc2)S1 |
| 存储 | Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 | ||||||||||
| 溶解度信息 | DMSO:PBS(pH 7.2) (1:3): 0.5 mg/mL (1.46 mM), Sonication is recommended. DMSO: 34 mg/mL (99.01 mM), Sonication is recommended. DMF: 25 mg/mL (72.8 mM), Sonication is recommended. Ethanol: 1 mg/mL (2.91 mM), Sonication is recommended. | ||||||||||
溶液配制表 | |||||||||||
该溶液配制表仅适用于固体产品。对于液体产品,请根据标明的浓度或密度计算稀释方案。 | |||||||||||
对于不同动物的给药剂量换算,您也可以参考 更多